Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial Earlier detection of cancer offers an opportunity to ...
As cell and gene therapies (CGTs) continue to advance, they have unique developmental features that may require innovation in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results